BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22810642)

  • 1. [The role of mucolytic therapy in the treatment of sinobronchial syndrome].
    Zaĭtseva OV
    Vestn Otorinolaringol; 2012; (2):63-5. PubMed ID: 22810642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
    Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of myrtol standardized on human nasal ciliary beat frequency and mucociliary transport time.
    Han D; Wang N; Zhang L
    Am J Rhinol Allergy; 2009; 23(6):610-4. PubMed ID: 19822035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.
    Meister R; Wittig T; Beuscher N; de Mey C
    Arzneimittelforschung; 1999 Apr; 49(4):351-8. PubMed ID: 10337455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bronchitis and sinusitis. Effective treatment by stimulating mucociliary clearance].
    MMW Fortschr Med; 2012 Nov; 154(20):70-1. PubMed ID: 23234125
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study].
    Sengespeik HC; Zimmermann T; Peiske C; de Mey C
    Arzneimittelforschung; 1998 Oct; 48(10):990-4. PubMed ID: 9825116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary disease.
    Cao L; Chen Y; Zhao Y; Zhang H; Wang S; Wang Z; Kang J
    Arzneimittelforschung; 2011; 61(12):685-92. PubMed ID: 22282955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mucolytic therapy of sinusitis].
    Riazantsev SV; Konoplev OI; Sapova KI
    Vestn Otorinolaringol; 2014; (6):61-63. PubMed ID: 25734312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis.
    Gillissen A; Wittig T; Ehmen M; Krezdorn HG; de Mey C
    Drug Res (Stuttg); 2013 Jan; 63(1):19-27. PubMed ID: 23447044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Qualitatively reliable study proves: in chronic bronchitis or COPD--standardized Myrtol].
    MMW Fortschr Med; 2004 May; 146(19):56-7. PubMed ID: 15357482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oxytetracycline + myrtol standardized in sinusitis and bronchitis. General practice test passed with "very good"].
    MMW Fortschr Med; 2006 Jan; 148(1-2):49. PubMed ID: 16610419
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in comparison with other treatments in the daily practice/results of a prospective cohort study].
    Goos KH; Albrecht U; Schneider B
    Arzneimittelforschung; 2006; 56(3):249-57. PubMed ID: 16618018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [N-acetylcystein in the therapy of chronic bronchitis].
    Reichenberger F; Tamm M
    Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters.
    Begrow F; Böckenholt C; Ehmen M; Wittig T; Verspohl EJ
    Adv Ther; 2012 Apr; 29(4):350-8. PubMed ID: 22477544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies on the mucolytic effectiveness of Mucosolvin oral and Mucosolvin inhalant].
    Fischer JF; Scheuler D
    Z Erkr Atmungsorgane; 1986; 167(1-2):96-102. PubMed ID: 3765720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucolytic and antibiotic effect of a new compound in chronic bronchitis.
    Bŭrgi H
    Chemotherapy; 1975; 21(3-4):167-74. PubMed ID: 1098866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetylcysteine in bronchitis and pneumonia].
    Vogelmeier C
    Internist (Berl); 1999 Oct; 40(10):1102-3. PubMed ID: 10610368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of erythromycin on mucociliary transport and clinical symptoms in patients with sinobronchial syndrome].
    Nishi K; Myou S; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1367-76. PubMed ID: 8277605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of Myrtol standardized in the treatment of children with acute rhinosinusitis].
    Karpova EP; Tulupov DA; Emel'yanova MP
    Vestn Otorinolaringol; 2016; 81(1):47-50. PubMed ID: 26977569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucolytic agents.
    Br Med J; 1971 Jun; 2(5761):581-2. PubMed ID: 5579199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.